Financial reports
NT 10-Q
Notice of late quarterly filing
16 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
13 May 22
10-K
2021 FY
Annual report
15 Apr 22
NT 10-K
Notice of late annual filing
28 Mar 22
10-Q
2021 Q3
Quarterly report
22 Nov 21
NT 10-Q
Notice of late quarterly filing
8 Nov 21
10-Q
2021 Q2
Quarterly report
23 Aug 21
NT 10-Q
Notice of late quarterly filing
13 Aug 21
Current reports
8-K
Changes in Registrant's Certifying Accountant
16 Aug 22
8-K
Other Events
24 Jun 22
8-K
Entry into a Material Definitive Agreement
16 Jun 22
8-K
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions
4 May 22
8-K
Changes in Registrant's Certifying Accountant
27 Apr 22
8-K
Medolife Rx Schedules Conference Call with Investment Community To Discuss Third Quarter 2021 Financial and Operational Results and New Updates
19 Nov 21
8-K/A
Entry into a Material Definitive Agreement
29 Sep 21
8-K
Medolife Rx Reports Second Quarter 2021 Financial and Operational Results, Schedules Conference
24 Aug 21
8-K
Other Events
29 Jul 21
8-K
Entry into a Material Definitive Agreement
2 Jul 21
Registration and prospectus
S-8
Registration of securities for employees
14 Jan 22
1-A/A
Offering $5M in Equity
27 Jul 21
1-A
Offering $5M in Equity
18 Jun 21
S-1/A
IPO registration (amended)
9 Feb 21
S-1
IPO registration
2 Feb 21
S-1
IPO registration
2 Sep 20
S-1
IPO registration
10 Apr 20
424B1
Prospectus with pricing info
14 Feb 20
S-1/A
IPO registration (amended)
13 Feb 20
S-1
IPO registration
15 Jan 20
Other
REVOKED
Registration or securities revoked
16 May 23
SEC STAFF
SEC staff action: Order
2 Sep 22
SEC STAFF ACTION
SEC staff action: Order
1 Sep 22
EFFECT
Notice of effectiveness
12 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
UPLOAD
Letter from SEC
3 Feb 21
EFFECT
Notice of effectiveness
14 Sep 20
CORRESP
Correspondence with SEC
8 Sep 20
UPLOAD
Letter from SEC
8 Sep 20
EFFECT
Notice of effectiveness
14 Feb 20